Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Domingo

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2023
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthmaDaniel J Jackson, Leonard B Bacharier, Wanda Phipatanakul, et al.
ERJ Open Research|November 29, 2023
Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi studyWoo-Jung Song, Lieven Dupont, Surinder S Birring, et al.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
ERJ Open Research|September 24, 2025
The NEuroCOUGH Chronic Cough Registry: a protocol for a pan-European observational studyPeter S P Cho, Surinder S Birring, Clíona McDowell, et al.
Open Respiratory Archives|October 6, 2025
[Consensus document for Severe Asthma. 2025 Update]Francisco Javier Álvarez-Gutiérrez, Marina Blanco Aparicio, Francisco Casas Maldonado, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2023
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthmaDaniel J Jackson, Leonard B Bacharier, Wanda Phipatanakul, et al.
ERJ Open Research|November 29, 2023
Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi studyWoo-Jung Song, Lieven Dupont, Surinder S Birring, et al.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
ERJ Open Research|September 24, 2025
The NEuroCOUGH Chronic Cough Registry: a protocol for a pan-European observational studyPeter S P Cho, Surinder S Birring, Clíona McDowell, et al.
Open Respiratory Archives|October 6, 2025
[Consensus document for Severe Asthma. 2025 Update]Francisco Javier Álvarez-Gutiérrez, Marina Blanco Aparicio, Francisco Casas Maldonado, et al.
Pageof 11